Back to funds
View filing
Cormorant Asset Management, LP
hedge fundUpdated 27 days agoManaged by Cormorant Asset Management, Lp • Latest filing Q2 2026
Portfolio value
$2B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
9.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.5B |
| Q2 2023 | $1.8B |
| Q3 2023 | $1.7B |
| Q4 2023 | $2.1B |
| Q1 2024 | $2.3B |
| Q2 2024 | $1.7B |
| Q3 2024 | $1.9B |
| Q4 2024 | $1.8B |
| Q1 2025 | $1.3B |
| Q2 2025 | $1.3B |
| Q3 2025 | $1.4B |
| Q4 2025 | $2.2B |
| Q1 2026 | $2B |
| Q2 2026 | $2B |
Top holdings
50 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PRAX PRAXIS PRECISION MEDICINES I | $214.3M | 640.0K | 10.98% | — |
| 2 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $136.2M | 17.88M | 6.98% | — |
| 3 | P PBLS PARABILIS MEDICINES INC | $126.3M | 4.62M | 6.47% | — |
| 4 | R RAPP RAPPORT THERAPEUTICS INC | $110.7M | 2.66M | 5.67% | — |
| 5 | E EQR ERASCA INC | $109.9M | 6.00M | 5.63% | — |
| 6 | E EWTX EDGEWISE THERAPEUTICS INC | $102M | 2.51M | 5.23% | — |
| 7 | ? N/A EYEPOINT INC | $100.1M | 7.00M | 5.13% | — |
| 8 | A ALMS ALUMIS INC | $92.5M | 3.29M | 4.74% | — |
| 9 | A AAVXF ABIVAX SA | $90M | 675.0K | 4.61% | — |
| 10 | D DNTH DIANTHUS THERAPEUTICS INC | $73.1M | 750.0K | 3.75% | — |
| 11 | D DRUG BRIGHT MINDS BIOSCIENCES INC | $63.2M | 900.0K | 3.24% | — |
| 12 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $62.4M | 3.21M | 3.20% | — |
| 13 | ? N/A BIOAGE LABS INC | $58.6M | 2.39M | 3.00% | — |
| 14 | O ORKA ORUKA THERAPEUTICS INC | $50.8M | 533.3K | 2.60% | — |
| 15 | A ANL ADLAI NORTYE LTD | $45.7M | 3.98M | 2.34% | — |
| 16 | B BBIO BRIDGEBIO PHARMA INC | $41M | 550.0K | 2.10% | — |
| 17 | T TNGX TANGO THERAPEUTICS INC | $40.6M | 1.30M | 2.08% | — |
| 18 | B BHVN BIOHAVEN LTD | $38.8M | 2.61M | 1.99% | — |
| 19 | A AGMB AGOMAB THERAPEUTICS NV | $32M | 2.47M | 1.64% | — |
| 20 | M MBX MBX BIOSCIENCES INC | $30.4M | 550.0K | 1.56% | — |